Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (1): 76-84.doi: 10.3736/jcim20120112

• Original Experimental Research • Previous Articles     Next Articles

Effects of extracts from Panax ginseng, Panax notoginseng and Ligusticum chuanxiong on expression of β-galactosidase and signal pathway p16-cyclin D/CDK-Rb in vascular smooth muscle cells

Tao Li-li1,Lei Yan2()   

  1. 1. Cardiovascular Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
    2. Medical Experiment Center, China Academy of Chinese Medical Sciences, Beijing 100700, China
  • Received:2011-08-04 Accepted:2011-09-12 Online:2012-01-20 Published:2018-09-21
  • Contact: Lei Yan

OBJECTIVE: To observe the pathological changes of vascular aging in spontaneously hypertensive rats (SHRs), and the effects of extracts from Panax ginseng, Panax notoginseng (Burk.) and Ligusticum chuanxiong on vascular aging.METHODS: Vascular smooth muscle cells (VSMCs) isolated from thoracic aorta of Wistar-Kyoto (WKY) rats and SHRs were primarily cultured and divided into WKY group, SHR group, valsartan group, low-dose extract group and high-dose extract group. Aging situation of VSMCs was detected by senescence-associated β-galactosidase (SA-β-gal) staining; the cell cycle was analyzed by flow cytometry; mRNA and protein expressions of p16, cyclin D1, cyclin-dependent kinase 4 (CDK4) and retinoblastoma protein (Rb) were detected by real-time fluorescence quantitative polymerase chain reaction (PCR) and Western blotting.RESULTS: SA-β-gal stain showed that compared with the WKY group, number of SA-β-gal-positive cells in the SHR group was increased significantly (P<0.01); extracts from Panax ginseng, Panax notoginseng (Burk.) and Ligusticum chuanxiong reduced the number of SA-β-gal-positive cells in the SHR group (P<0.01). Flow cytometry analysis showed that the number of VSMCs in G1 phase was reduced and in S phase was increased significantly (P<0.05) in the SHR group compared with the WKY group, and the number of VSMCs in G1 phase was increased and in S phase was reduced significantly in the extracts groups (P<0.05). PCR result showed that compared with the WKY group, the mRNA expressions of p16 and Rb in the SHR group were reduced and those of cyclin D1 and CDK4 were increased significantly, the mRNA expressions of p16 and Rb in the extracts group were increased and mRNA expressions of cyclin D1 and CDK4 were reduced significantly. Western blotting result showed that compared with the WKY group, the protein expression of p16 in the SHR group was reduced and the protein expressions of cyclin D1, CDK4 and phospho-Rb were increased significantly (P<0.05), while the protein expression of p16 in the extracts group was increased and the protein expressions of cyclin D1, CDK4 and phospho-Rb were reduced significantly (P<0.05).CONCLUSION: The extracts from Panax ginseng, Panax notoginseng (Burk.) and Ligusticum chuanxiong can delay vascular aging of SHRs, which works by p16-cyclin D/CDK-RB pathways to inhibit VSMC proliferation.

Key words: hypertension, vascular aging, plant extracts, senescence-associated β-galactosidase;, gene, p16, cyclin D1, cyclin-dependent kinase 4, retinoblastoma protein

Figure 1

Growth morphology of VSMCs and identificationA: Cells obtained from aorta of rats had a spindle shape (Inverted microscopy, ×200); B: Cells displayed a hill-and-valley pattern typical for VSMCs (Inverted microscopy, ×100); C: Percentage of α-actin-positive smooth muscle cells was more than 95% (Inverted microscopy, ×400). VSMCs: vascular smooth muscle cells."

Table 1

SA-β-gal-positive VSMCs in different groups ($\bar{x}$±s, %)"

Group n SA-β-gal-positive VSMCs
Wistar-Kyoto 3 11.14±2.21
SHR 3 32.89±3.14**
Valsartan 3 15.96±1.59△△
Low-dose extract 3 24.36±2.00△△
High-dose extract 3 20.78±1.86△△

Figure 2

SA-β-gal-positive VSMCs in different groups (×400) A: Wistar-Kyoto group; B: Spontaneously hypertensive rat group; C: Valsartan group; D: Low-dose extract (20 mg/L) group; E: High-dose extract (40 mg/L) group. SA-β-gal: senescence-associated β-galactosidase; VSMC: vascular smooth muscle cell."

Table 2

Cell cycle analysis of VSMCs ($\bar{x}$±s, %)"

Group n G1 phase G2 phase S phase
Wistar-Kyoto 3 91.23±1.10 6.75±0.83 2.02±1.21
SHR 3 67.40±0.85* 17.43±0.34* 15.17±0.99*
Valsartan 3 87.90±8.49 10.53±0.96 2.71±1.57
Low-dose extract 3 81.67±0.81 15.12±0.17 3.22±0.91
High-dose extract 3 85.43±0.96 7.53±0.56 7.03±1.52

Figure 3

Cell cycle analysis of VSMCsA: Wistar-Kyoto group; B: Spontaneously hypertensive rat group; C: Valsartan group; D: Low-dose extract (20 mg/L) group; E: High-dose extract (40 mg/L) group. VSMC: voscular smooth muscle cell."

Table 3

Expressions of p16, cyclin D1, CDK4 and Rb mRNAs in VSMCs ($\bar{x}$±s)"

Group n p16 Cyclin D1 CDK4 Rb
Wistar-Kyoto 3 3.31±0.06 0.27±0.02 1.01±0.02 2.87±0.04
SHR 3 0.79±0.38* 1.25±0.24* 3.14±0.19* 0.57±0.49*
Valsartan 3 2.52±0.12 0.45±0.03 1.24±0.01 2.30±0.17
Low-dose extract 3 1.39±0.11 0.77±0.10 3.01±0.30 1.17±0.32
High-dose extract 3 1.76±0.21 0.63±0.15 2.70±0.09 1.74±0.05

Table 4

Expressions of p16, cyclinD1 and CDK4 proteins and pRb in VSMCs ($\bar{x}$±s)"

Group n p16 Cyclin D1 CDK4 pRb
Wistar-Kyoto 3 1.19±0.31 0.82±0.06 1.37±0.13 0.50±0.14
SHR 3 0.51±0.06* 2.17±0.35* 2.17±0.27* 1.34±0.08*
Valsartan 3 0.89±0.23 0.93±0.07 0.95±0.20 0.56±0.01
Low-dose extract 3 1.04±0.14 1.52±0.32 1.81±0.13 1.19±0.21
High-dose extract 3 1.03±0.09 1.47±0.15 2.00±0.35 0.86±0.07

Figure 4

Expressions of p16, cyclinD1, CDK4 proteins and pRb in VSMCsA: Wistar-Kyoto group; B: SHR group; C: Valsartan group; D: Low-dose extract (20 mg/L) group; E: High-dose extract (40 mg/L) group. SHR: spontaneously hypertensive rat; VSMC: vascular smooth muscle cell; CDK4: cyclin-dependent kinase 4; pRb: phospho-retinoblastoma protein."

[1] Laurent S, Vanhoutte P, Cavero I, Chabrier PE, Dupuis B, Elghozi JL, Hamon G, Janiak P, Juillet Y, Kher A, Koen R, Madonna O, Maffrand JP, Pruneau D, Thuillez C . The arterial wall : a new pharmacological and therapeutic target. Fundam Clin Pharmacol. 1996; 10(3) : 243-257.
[2] Arterial aging and hypertension (to be continued) . Zhonghua Gao Xue Ya Za Zhi. 2007; 15(10) : 866-867. Chinese.
动脉老化与髙血压( 待续). 中华髙血压杂志. 2007; 15(10) : 866-867.
[3] Yang J, Lei Y, Fang SP, Cui W , Chen KJ. Study on acting mechanism of extracts from ginseng, notoginseng and Chuanxiong for delaying the aging of endothelial cells induced by angiotensin. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009; 29(6):524-528. Chinese with abstract in English.
杨静, 雷燕, 方素萍, 崔巍, 陈可冀 . 人参三七川芎提取物延缓血管紧张素n诱导内皮细胞衰老机制的研究. 中国中西医结合杂志. 2009; 29(6):524-528.
[4] Ma L, Liu SJ, Deng YZ, Sun ZQ , Li YF. A method to isolate, culture and identify smooth muscle cells from rat thoracic artery. Zhongguo Xin Xue Guan Bing Yan Jiu Za Zhi. 2007 ; 5(5) : 363-365. Chinese with abstract in English.
马丽, 刘苏健, 邓勇志, 孙宗全, 栗一帆 . 大鼠胸主动脉平滑肌细胞的培养与鉴定.中国心血管病研究杂志. 2007; 5(5) : 363-365.
[5] Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J . A biomarker that identifies senescent human cells in culture and in aging skin in vivo . Proc Natl Acad Sci USA. 1995; 92(20) : 9363-9367.
[6] Situ ZQ, Wu JZ. Cell culture. 2nd ed. Xi'an: World Publishing Corporation. 2007: 200-201. Chinese.
司徒镇强, 吴军正 .细胞培养. 第2版.西安: 世界图书出版公司. 2007: 200-201.
[7] Varagic J, Susie D, Frohlich E . Heart, aging and hypertension. Curr Opin Cardiol. 2001 ; 16(6):336-341.
[8] Ruan YJ, Yin MZ , Wu SZ. Research on vascular aging. Shi Yong Lao Nian Yi Xue. 2006; 20(6):418-420. Chinese.
阮云军, 银孟卓, 吴赛珠 . 血管老化的研究进展.实用老年医学. 2006; 20(6):418-420.
[9] Wen JK, Han M. Supplementing qi and activating blood circulation in gene regulation of vascular smooth muscle cells. J Chin Integr Med. 2003; 1(1):12-14. Chinese with abstract in English.
温进坤, 韩梅 . 益气活血法与血管平滑肌细胞基因表达调节.中西医结合学报. 2003; 1(1):12-14.
[10] JinJS, Zhao CH, Chen XC, Zhu YG, Zeng YQ, Li YK, Peng XS , Shi GB. Antiaging effect of ginsenoside Rgl is related with expressions of pi 6, cyclin D1 and CDK4. Zhongguo Lin Chuang Yao Li Xue Yu Zhi Liao Xue. 2004; 9(1):29-34. Chinese with abstract in English.
金建生, 赵朝晖, 陈晓春, 朱元贵, 曾育琦, 李永坤, 彭小松, 师广斌 . 人参阜苷Rgl抗衰老作用可能与改变pl6, cyclinD,CDK4的表达有关.中国临床药理学与治疗学. 2004; 9(1):29-34.
[11] Chen XC, Zhu YG, Wang XZ, Zhu LA, Huang C . Protective effect of ginsenoside Rgl on dopamine- induced apoptosis in PCI2 cells. Acta Pharmacol Sin. 2001; 22(8) : 673-678.
[12] Xue LX, Li J, Zhang ZY, Tong TJ. Cell senescence and transcriptional regulation of pl6 INK4a. Yi Xue Fen Zi Sheng Wu Xue Za Zhi. 2006; 3(1):29-31. Chinese with abstract in English.
薛丽香, 李琚, 张宗玉, 童坦君 . 细胞衰老与pl6 INK4a 的转录调控.医学分子生物学杂志 . 2006; 3(1):29-31.
[13] Hu ZW, Zhou YP , Shen ZY. Research progress of the relationship between pi6 and cell senescence. Guo Wai Yi Xue Yi Chuan Xue Fen Ce. 2004; 27(4):200-202. Chinese.
胡作为, 周燕萍, 沈自尹 . Pl6基因与细胞衰老关系的研究进展.国外医学遗传学分册. 2004; 27(4):200-202.
[14] Ou Q, Wang YL, Wei XD , Zhang YC. Effect of Fructus corni polysaccharides on the activity of p-galactosidase and the expression of pi 6. Zhongguo Lao Nian Xue Za Zhi. 2007 ; 4(27):325-327. Chinese with abstract in English.
欧芹, 王雅丽, 魏晓东, 张玉成 . 山茱萸多糖对HDF 细胞卩-半乳糖苷酶及Pl6表达的影响.中国老年学杂志. 2007; 4(27):325-327.
[15] Thomas NS, Pizzey AR, Tiwari S, Williams CD , Yang J. pi30,pl07, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by a-inter- feron.J Biol Chem. 1998; 273(37):23659-23667.
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Yen-Lin Chao, Yi-Ai Rau, Hong-Sheng Shiue, Jiun-Lin Yan, Yuan-Yun Tang, Shao-Wen Yu, Bo-Yan Yeh, Yen-Lung Chen, Tsung-Hsien Yang, Shu-Chen Cheng, Yi-Wen Hsieh, Hsin-Chia Huang, Fu-Kuang Tsai, Yu-Sheng Chen, Geng-Hao Liu. Using a consensus acupoints regimen to explore the relationship between acupuncture sensation and lumbar spinal postoperative analgesia: A retrospective analysis of prospective clinical cooperation. Journal of Integrative Medicine, 2022, 20(4): 329-337.
[3] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[4] Shuai Chen, Jin Hu, Deng-cheng Lu, Hong-yi Liu, Shan-shan Wei. Metabolomic characteristics of spontaneously hypertensive rats under chronic stress and the treatment effect of Danzhi Xiaoyao Powder, a traditional Chinese medicine formula. Journal of Integrative Medicine, 2022, 20(1): 73-82.
[5] Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[6] Rakhi Chakraborty, Swarnendu Roy. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. Journal of Integrative Medicine, 2021, 19(6): 478-492.
[7] Yang-hao-tian Wu, Wen-bo He, Yin-yan Gao, Xue-mei Han. Effects of traditional Chinese exercises and general aerobic exercises on older adults with sleep disorders: A systematic review and meta-analysis. Journal of Integrative Medicine, 2021, 19(6): 493-502.
[8] Victor Abou Nehmi Filho, Gilson Masahiro Murata, Ruan Carlos Macêdo de Moraes, Gabriely Cristina Alves Lima, Danielle Araujo de Miranda, Katrin Radloff, Raquel Galvão Figuerêdo Costa, Joyce de Cassia Rosa de Jesus, Jéssica Alves De Freitas, Nayara Izabel Viana, Ruan Pimenta, Katia Ramos Moreira Leite, José Pinhata Otoch, Ana Flávia Marçal Pessoa. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice. Journal of Integrative Medicine, 2021, 19(5): 439-450.
[9] Reem Abdul-Latif, Ieva Stupans, Ayman Allahham, Benu Adhikari, Thilini Thrimawithana. Natural antioxidants in the management of Parkinson’s disease: review of evidence from cell line and animal models. Journal of Integrative Medicine, 2021, 19(4): 300-310.
[10] Ju-Yeon Park, Young-Won Kwon, Sun-Ah Kim, Sun-Dong Park, Chang-Hyun Kim, Jin-Hee Kim, Ju-Hee Lee. Polyherbal formula SC-E3 inhibits rheumatoid arthritis activity in a mouse model of type-II collagen-induced arthritis. Journal of Integrative Medicine, 2021, 19(3): 265-273.
[11] Mu-yan Kong, Le-yan Li, Yan-mei Lou, Hong-yu Chi, Jin-jun Wu. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. Journal of Integrative Medicine, 2020, 18(5): 369-384.
[12] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[13] Pranay Soni, Rajesh Choudhary, Surendra H. Bodakhe. Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataract. Journal of Integrative Medicine, 2019, 17(5): 374-382.
[14] Stefania Lamponi, Anna Maria Aloisi, Claudia Bonechi, Marco Consumi, Alessandro Donati, Gemma Leone, Claudio Rossi, Gabriella Tamasi, Luana Ghiandai, Ersilia Ferrini, Paolo Fiorenzani, Ilaria Ceccarelli, Agnese Magnani. Evaluation of in vitro cell and blood compatibility and in vivo analgesic activity of plant-derived dietary supplements. Journal of Integrative Medicine, 2019, 17(3): 213-220.
[15] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
Full text



[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239